Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
99 (46%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT CELECOXIB | 100MG | CAPSULE | Resolved | 2019-08-22 | 2021-02-12 | 92232 |
| ACT CELECOXIB | 100MG | CAPSULE | Resolved | 2021-01-28 | 2021-02-12 | 132669 |
| ACT CELECOXIB | 100MG | CAPSULE | Resolved | 2017-03-17 | 2018-10-11 | 3390 |
| ACT CIPROFLOXACIN | 500MG | TABLET | Resolved | 2021-02-05 | 2023-06-09 | 133460 |
| ACT CIPROFLOXACIN | 250MG | TABLET | Resolved | 2023-06-19 | 2023-07-05 | 195585 |
| ACT CIPROFLOXACIN | 250MG | TABLET | Resolved | 2021-11-25 | 2023-10-05 | 149931 |
| ACT CIPROFLOXACIN | 500MG | TABLET | Resolved | 2018-12-04 | 2019-03-12 | 68599 |
| ACT CIPROFLOXACIN | 750MG | TABLET | Resolved | 2021-11-25 | 2022-02-05 | 149934 |
| ACT CIPROFLOXACIN | 500MG | TABLET | Resolved | 2019-09-12 | 2019-10-10 | 93644 |
| ACT CIPROFLOXACIN | 500MG | TABLET | Resolved | 2019-06-18 | 2019-07-15 | 86923 |
| ACT CIPROFLOXACIN | 250MG | TABLET | Resolved | 2020-05-08 | 2020-05-21 | 114436 |
| ACT CIPROFLOXACIN | 750MG | TABLET | Resolved | 2018-09-12 | 2018-10-11 | 61365 |
| ACT CIPROFLOXACIN | 500MG | TABLET | Resolved | 2020-04-02 | 2020-05-21 | 110643 |
| ACT CIPROFLOXACIN | 750MG | TABLET | Resolved | 2020-04-02 | 2020-09-03 | 110646 |
| ACT CIPROFLOXACIN | 750MG | TABLET | Resolved | 2022-10-28 | 2023-06-09 | 173040 |
| ACT CLARITHROMYCIN XL | 500MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-07-09 | 2023-04-28 | 119901 |
| ACT CLARITHROMYCIN XL | 500MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-01-09 | 2020-05-29 | 102945 |
| ACT CLARITHROMYCIN XL | 500MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-11 | 2024-05-16 | 215737 |
| ACT DEXTROAMPHETAMINE SR | 15MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2022-03-04 | 2022-03-24 | 156064 |
| ACT DEXTROAMPHETAMINE SR | 10MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2020-10-08 | 2020-10-15 | 126029 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ENALAPRIL | 16MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64866 |
| TEVA-ENALAPRIL | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64869 |
| TEVA-FAMOTIDINE | 20MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81371 |
| TEVA-FINGOLIMOD | 0.5MG | CAPSULE | Discontinued | 2025-03-20 | 2025-03-20 | 253186 |
| TEVA-FLUCONAZOLE | 100MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256091 |
| TEVA-FLUCONAZOLE | 50MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256137 |
| TEVA-FUROSEMIDE | 20MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14039 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14042 |
| TEVA-HALOPERIDOL | 20MG | TABLET | Discontinued | 2019-10-25 | 2019-10-26 | 97270 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64970 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64975 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64983 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64993 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106158 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106161 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106164 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106167 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
| TEVA-IRBESARTAN HCTZ | 300MG 25MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231580 |
| TEVA-IRBESARTAN HCTZ | 300MG 12.5MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231577 |